In rodent models of SOD1‐ALS, the orally available and brain‐penetrant copper compound CuATSM has been found to mitigate symptoms of motor neuron decline and extend survival without adverse effects [3, 4, 5, 6, 7, 8]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.